⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2828995 | 0.96 | — | — | |
| SCHEMBL8000974 | 0.96 | — | — | |
| SCHEMBL290664 | 0.86 | — | — | |
| SCHEMBL3857734 | 0.85 | CES1 (0.32) | — | |
| SCHEMBL5356778 | 0.83 | CES1 (0.35) | — | |
| SCHEMBL581064 | 0.83 | CES1 (0.35) | — | |
| SCHEMBL5651324 | 0.83 | CES1 (0.35) | — | |
| SCHEMBL2305639 | 0.83 | CES1 (0.35) | — | |
| SCHEMBL2285351 | 0.83 | CES1 (0.35) | — | |
| SCHEMBL514303 | 0.83 | CES1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12459907-B2 | Process for the production of ozanimod | EGIS GYOGYSZERGYAR ZRT. (HU) | 2025-11-04 | — | — | US | claimed |
| CN-117949549-A | Method for measuring sorbitol nucleating agent content in polypropylene | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| EP-3630738-B1 | PROCESS FOR THE PRODUCTION OF OZANIMOD | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 2023-07-19 | — | — | EP | claimed |
| CN-115746228-B | AB prepared by using polyfluorene as initiator 2 Method for synthesizing block copolymer | 常州工程职业技术学院 | 2023-05-09 | — | — | CN | claimed |
| CN-115746228-A | Preparation of AB by using polyfluorene as initiator 2 Method for synthesizing block copolymer | 常州工程职业技术学院 | 2023-03-07 | — | — | CN | claimed |
| CN-115286616-A | Tetrahydroisoquinoline and isoindoline compound capable of binding sigma-2 receptor, preparation method and application thereof | 北京师范大学 | 2022-11-04 | — | — | CN | claimed |
| WO-2022037365-A1 | DOUBLE-TARGET INHIBITOR TARGETING FGFR AND HDAC, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITION AND MEDICAMENT | 四川大学华西医院 | 2022-02-24 | — | — | WO | claimed |
| CN-112920167-A | Double-target inhibitor targeting FGFR and HDAC, preparation method and application thereof, pharmaceutical composition and medicament | 四川大学华西医院 | 2021-06-08 | — | — | CN | claimed |
| EP-3406142-B1 | SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS | CELGENE INT II SARL (CH) | 2020-12-23 | — | — | EP | claimed |
| CN-112062785-A | Preparation method of ozapimod and intermediate thereof | 广东东阳光药业有限公司 | 2020-12-11 | — | — | CN | claimed |
| CN-110997645-A | Preparation method of ozanimod | 埃吉斯制药公司 | 2020-04-10 | — | — | CN | claimed |
| US-20200087269-A1 | PROCESS FOR THE PRODUCTION OF OZANIMOD | EGIS GYOGYSZERGYAR ZRT. (HU) | 2020-03-19 | — | — | US | claimed |
| WO-2026106389-A1 | NMT INHIBITOR AND USE THEREOF | 주식회사 이노보테라퓨틱스 | 2026-05-21 | — | — | WO | disclosed |
| US-12630530-B2 | FGFR inhibitor compound and use thereof | HENAN MEDINNO PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-05-19 | — | — | US | disclosed |
| US-20260132132-A1 | 3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS | KALVISTA PHARMACEUTICALS LTD (GB) | 2026-05-14 | — | — | US | disclosed |
| EP-4355748-B1 | SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | SANOFI SA (FR) | 2026-05-13 | — | — | EP | disclosed |
| WO-1999031068-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999005143-A1 | NOVEL COMPOUNDS | ASTRA PHARMACEUTICALS LTD. (GB) | 1999-02-04 | — | — | WO | disclosed |
| WO-1998035978-A9 | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | — | 1999-01-14 | — | — | WO | disclosed |
| WO-1998035978-A1 | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1998-08-20 | — | — | WO | disclosed |